News
Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...
EUROPEAN shares tumbled further on Wednesday as China more than doubled its tariffs on US imports, with healthcare stocks ...
Trump said overnight that the US would soon introduce a 'major tariff' on pharmaceuticals to force firms to relocate medicine production to America.
7h
NewsNation on MSNAstraZeneca’s pill cuts cholesterol, offers convenient treatmentAstraZeneca’s experimental pill has shown promise in reducing “bad” cholesterol, raising expectations for more convenient alternatives in treatment options. AstraZenca is testing a once-daily PCSK9 ...
AstraZeneca Pharmaceuticals LP and a Christian sales specialist have agreed to settle his suit over the company’s failure to ...
Pharmaceutical imports became the latest target for President Donald Trump’s tariffs, sending FTSE 100 drugmakers stock into ...
AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...
Shares in many large drugmakers initially fell Wednesday on the president's threat, only to rebound later when he announced a ...
Investors are nervous. As of 9:55 a.m. ET Wednesday morning, shares of Roche Holding ( RHHBY -2.81%) are down 2.3%, Eli Lilly ( LLY -4.38%) stock is off 3.2%, and AstraZeneca ( AZN -4.87%) is doing ...
Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £153.18. The ...
FTSE 100 giants have been caught in the crosshairs of the US and China's escalating trade war leaving investors panicked.
In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results